-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – XH-001 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - XH-001 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. XH-001 in Solid Tumor Drug Details: XH-001 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AT-002 in Uveitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AT-002 in Uveitis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AT-002 in Uveitis Drug Details: AT-002 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AT-002 in Dermatomyositis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AT-002 in Dermatomyositis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AT-002 in Dermatomyositis Drug Details: AT-002 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GBM-2 in Glioblastoma Multiforme (GBM)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GBM-2 in Glioblastoma Multiforme (GBM) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GBM-2 in Glioblastoma Multiforme (GBM) Drug Details: Small molecule is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VENT-02 in Neurodegenerative Diseases
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VENT-02 in Neurodegenerative Diseases report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VENT-02 in Neurodegenerative Diseases Drug Details: VENT-02 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VENT-02 in Neuroinflammation
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VENT-02 in Neuroinflammation report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VENT-02 in Neuroinflammation Drug Details: VENT-02 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ANX-009 in Lupus Nephritis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ANX-009 in Lupus Nephritis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ANX-009 in Lupus Nephritis Drug Details: ANX-009 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pilocarpine in Keratoconjunctivitis Sicca (Dry Eye)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pilocarpine in Keratoconjunctivitis Sicca (Dry Eye) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pilocarpine in Keratoconjunctivitis Sicca (Dry Eye) Drug Details: Pilocarpine is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – 4B-0601 in Amyotrophic Lateral Sclerosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - 4B-0601 in Amyotrophic Lateral Sclerosis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. 4B-0601 in Amyotrophic Lateral Sclerosis Drug Details: FB-1006 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BBI-825 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BBI-825 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BBI-825 in Solid Tumor Drug Details: BBI-825 is under development for...